Previous Article | Next Article 
Applied and Environmental Microbiology, June 2001, p. 2596-2602, Vol. 67, No. 6
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.6.2596-2602.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Lovastatin Biosynthesis by Aspergillus
terreus in a Chemically Defined Medium
Hassan
Hajjaj,*
Peter
Niederberger, and
Philippe
Duboc
Nestlé Research Center, Nestec Ltd.,
Vers-chez-les-Blanc, CH-1000 Lausanne 26, Switzerland
Received 27 November 2000/Accepted 20 March 2001
 |
ABSTRACT |
Lovastatin is a secondary metabolite produced by Aspergillus
terreus. A chemically defined medium was developed in order to investigate the influence of carbon and nitrogen sources on lovastatin biosynthesis. Among several organic and inorganic defined nitrogen sources metabolized by A. terreus, glutamate and histidine
gave the highest lovastatin biosynthesis level. For cultures on glucose and glutamate, lovastatin synthesis initiated when glucose consumption levelled off. When A. terreus was grown on lactose,
lovastatin production initiated in the presence of residual lactose.
Experimental results showed that carbon source starvation is required
in addition to relief of glucose repression, while glutamate did not
repress biosynthesis. A threefold-higher specific productivity was
found with the defined medium on glucose and glutamate, compared to growth on complex medium with glucose, peptonized milk, and yeast extract.
 |
INTRODUCTION |
In filamentous fungi many secondary
metabolites with complex chemical structure are synthesized via the
polyketide pathway (15, 33, 37). Lovastatin, monacolin J,
monacolin L, and mevastatin can be produced by Monascus
ruber (7), Penicillium brevicompactum, and
Aspergillus terreus (1, 36). Lovastatin is an
inhibitor of the enzyme hydroxymethylglutaryl coenzyme A (HMG-CoA)
reductase (mevalonate:NADP+ oxidoreductase [EC 1.1.1.34])
that catalyzes the reduction of HMG-CoA to mevalonate during synthesis
of cholesterol (14, 23, 36). The biosynthetic pathway of
lovastatin in A. terreus has been investigated by nuclear
magnetic resonance and mass spectroscopy (5, 26, 38).
These studies concluded that lovastatin is composed of two distinct
polyketide chains joined through an ester linkage. Proof that these two
polyketides are assembled by two discrete polyketide synthases came
from the cloning and partial characterization of the lovastatin
biosynthetic gene cluster from A. terreus (16,
18).
Despite the knowledge of the genes and the enzymes involved in the
biosynthetic pathway, little is known about the regulation and the
physiology of lovastatin biosynthesis. Reported growth and production
conditions for lovastatin are from batch fermentations performed on
media with glucose and a complex nitrogen source (1, 4, 13, 22,
28). Both carbon and nitrogen sources are thought to exert
complex regulation on gene expression and enzyme activities for
polyketide synthesis, possibly at the level of catabolite repression or
signaling due to limitation in growth rate or substrate limitation.
The objective of this work was to investigate the influence of glucose
and nitrogen source on the physiology of A. terreus and
lovastatin production. Several carbon and nitrogen sources were tested
in order to develop a chemically defined medium. The aim was to monitor
biomass formation and lovastatin production in relation to the
consumption pattern of carbon and nitrogen sources. We show here that
although growth occurred on a large variety of substrates, the choice
of nitrogen source had a major impact on lovastatin production. In
addition, lovastatin biosynthesis was initiated only when assimilation
of the carbon source was limited.
 |
MATERIALS AND METHODS |
Microorganism and growth conditions.
Stock culture of
A. terreus Thom ATCC 74135 was maintained on potato dextrose
agar (Oxoid). The slants were stored at 4°C after growth on potato
dextrose agar for 8 days at 28°C. Conidiospores were harvested with
sterile solution (0.9% NaCl, 0.05% Tween 80), washed twice with
sterile buffer (20 mM KH2PO4, adjusted to pH 2.0 with HCl), and enumerated.
Culture on complex medium.
A 250-ml Erlenmeyer flask
containing 40 ml of medium A [10 g of glucose, 5 g of corn steep
liquor (Sigma catalog no. C-4648), 40 g of tomato paste, 10 g
of oatmeal, and 10 ml of trace elements
1 g of FeSO4
· 7H2O, 1 g of MnSO4 · 4H2O, 200 mg of ZnSO4 · 7H2O, 100 mg of CaCl2 · 2H2O, 25 mg of CuCl2 · 2H2O,
56 mg of H3BO3, and 19 mg of
(NH4)6Mo7O24 · 4H2O
per liter of solution (1)] was
inoculated with 2 · 106 conidiospores. The flasks
were shaken at 220 rpm for 1 day at 28°C. A second culture was
prepared by inoculating 200 ml of medium B (containing [per liter]
45 g of glucose or lactose, 24 g of peptonized milk [Oxoid
catalog no. LP032J], 2.5 g of yeast extract [Difco catalog no.
0127-17], 2.5 g of polyethylene glycol P2000 [Fluka
Chemika catalog no. 81221] [1]) with 6 ml of the
previous culture in a 1-liter Erlenmeyer flask. The flasks were shaken at 200 rpm and incubated at 28°C for 12 days. For cultivations in
fermentors, a 1-liter Erlenmeyer flask containing 200 ml of medium A
was inoculated with 4 ml (107) of conidiospore suspension.
The flask was shaken at 220 rpm for 1 day and then transferred to a
fermentor. Batch cultivations were performed in duplicate at 28°C in
a 7- or 15-liter bioreactor (New MBR, Zurich, Switzerland) with a
culture volume of 4 or 6 liters of medium B, respectively. The reactor
was inoculated with 3% inoculum. An overpressure of 0.3 · 105 Pa was applied to the reactor. Dissolved oxygen was
continuously monitored with an oxygen probe (Mettler Toledo,
Greifensee, Switzerland). The stirrer speed was kept at 400 rpm, and
the airflow rate was controlled at 0.4 or 1 vol/vol/min (vvm) use of a
mass flow meter (Bronkhorst, Ruurlo, The Netherlands).
Culture on synthetic medium.
The chemically defined
fermentation medium developed in this study contained (per liter of
distilled water) the following: 45 g of glucose (Fluka Chemika catalog
no. 49159), 12.5 g of mono-hydrate sodium glutamate (Merck catalog
no. 6445), 5 g of KH2PO4 (Merck catalog
no. 104873), 5 g of K2HPO4 (Merck catalog
no. 105101), 0.2 g of FeSO4 · 7H2O
(Merck catalog no. 3965), 0.1 g of MnSO4 · 4H2O (Merck catalog no. 102786), 0.2 g of
ZnSO4 · 7H2O (Merck catalog no. 8883),
0.1 g of MgSO4 · 7H2O (Fluka
Chemika catalog no. 63138), 20 mg of CaCl2 · 2H2O (Fluka Chemika catalog no. 21097), 5 mg of
CuCl2 · 2H2O (Merck catalog no. 2791),
11 mg of H3BO3 (Merck catalog no. 100165), and
5 mg of
(NH4)6Mo7O24 · 4H2O (Merck catalog no. 101182). The pH of the medium was
adjusted to 6.5 with HCl (2 N) or KOH (2 N). A suspension of
107 conidiospores was used to inoculate a 1-liter
Erlenmeyer flask containing 200 ml of medium with 10 g of glucose
liter
1. The inoculum was agitated at 200 rpm and
incubated at 28°C for 1 day and then transferred to a fermentor
containing 4.5 liters of synthetic medium. The cultivations were
performed at a temperature of 28°C, an agitation rate of 400 rpm, and
a volumetric aeration rate of 1 vvm.
Analytical methods.
Biomass was determined by gravimetric
analysis after filtration of cell samples through preweighed nylon
filters (45-mm diameter; pore size, 0.8 µm) and dried at 95°C to a
constant weight. Glucose, lactose, ethanol, and organic acid
concentrations in the filtrate were determined by high-performance
liquid chromatography (HPLC) (HPX-87H+ column; temperature,
35°C; mobile phase, 5 mM H2SO4; flow rate, 0.6 ml min
1; detection at 210 nm with a diode-array
detector). The concentration of amino acids in the medium was
determined by HPLC (Hewlett-Packard) on an AccQ Tag column (3.9 by 150 mm; Waters catalog no. WATO 52885), after derivatization of samples by
6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (Waters
AccQ-Fluor method). The two eluents were 10% AccQ Tag (Waters catalog
no. WATO 52890) (eluent A) and 60% acetonitrile (eluent B), and the
flow rate was 1 ml min
1. The following separation
gradient was applied to the first solvent: 0% eluent A to 100% eluent
B within 49 min and 100% eluent A to 0% eluent B within 11 min. The
detector used was a HP 1046A fluorimetric detector
(
EX = 250 nm and
EM = 395 nm).
Lovastatin was determined by HPLC. A Nucleosil 100-5 C18
column (250 by 4 mm; Macherey & Nagel) was used with a precolumn (Lichrospher 100 RP-18; Merck). Solvent A was 0.05%
H3PO4 in water, and solvent B was acetonitrile.
The separation gradient was linear, starting with 95% solvent A and
5% solvent B, reaching 50% solvent A and 50% solvent B in 45 min,
30% solvent A and 70% solvent B in 46 min, 10% solvent A and 90%
solvent B in 48 min, and 0% solvent A and 100% solvent B in 50 min
and finally continued with an isocratic run for 4 min. Initial
conditions were maintained for 6 min to reequilibrate the column. The
flow rate was 1 ml min
1. The absorption was measured at a
wavelength of 254 nm (Hewlett Packard G 1315 A, series 1100 detector).
The detection level in sample broth was 1 mg liter
1, and
we have confirmed the presence of lovastatin in the filtrate by mass
spectroscopy. For all HPLC methods, identities of metabolites were
confirmed by comparison of retention times with standards.
 |
RESULTS |
Batch fermentation of A. terreus in complex
medium.
A batch fermentation of A. terreus grown on
complex medium containing (per liter) 45 g of glucose, 24 g of
peptonized milk, and 2.5 g of yeast extract, is depicted in Fig.
1. Lactose (11 g liter
1)
detected at the beginning of the cultivation was derived from peptonized milk. Glucose was exhausted after 45 h of cultivation, while 11 g of lactose liter
1 remained in the medium
(Fig. 1A). pH decreased from 6.5 to 4.9 during the phase of glucose
consumption; thereafter pH increased slowly and reached 6.9 by the end
of the culture. At the time of glucose exhaustion the biomass
concentration was 24 g liter
1, corresponding to a
biomass yield on glucose of 0.55 g g
1. During the
glucose consumption phase, the specific growth rate, µ, was 0.07 h
1, and the specific glucose consumption rate,
qglucose, was 0.13 g g
1
h
1. Lactose was consumed upon glucose exhaustion, and the
biomass concentration reached 28 g liter
1. Ethanol
and CO2 were the main fermentation products, while acetate was produced at a very low level only. Ethanol accumulated in the
medium during the period of rapid glucose consumption. The maximal
ethanol concentration was 1.3 g liter
1 after 42 h of cultivation. Ethanol was consumed after glucose and was exhausted
after 80 h of cultivation. The gas exchange rates (Fig. 1B)
increased during biomass formation and reached a maximum value at the
time of glucose exhaustion.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Fermentation of A. terreus in complex medium
with glucose (45 g liter 1), peptonized milk (24 g
liter 1), and yeast extract (2.5 g liter 1)
at an aeration rate of 1 vvm and agitation speed of 400 rpm. (A)
Symbols: , glucose; , biomass; , lactose; , lovastatin. (B)
Symbols: , oxygen consumption rate
(rO2); , carbon dioxide production rate
(rCO2).
|
|
Lovastatin production started after approximately 45 h of
cultivation (Fig.
1A) when the residual glucose concentration was
2.5 g liter
1 and reached a concentration of 304 mg
liter
1 by the end of the fermentation (350 h). The
specific productivity,
qlovastatin, was 0.034 g
g
1 h
1. Neither monacolin J, monacolin L,
nor mevastatin was detected
in the fermentation
broth.
In a second experiment, lactose was tested as the sole nonrepressing
carbon source (Fig.
2), with an initial
concentration
of 53 g liter
1 (no glucose was
initially present in medium). Biomass was built
up within 50 h,
and from 50 to 200 h lactose was slowly consumed.
After 200 h no
lactose consumption was observed. The residual
lactose concentration
was about 25 g liter
1, and lovastatin started to be
produced at a constant rate of
1 mg liter
1
h
1 until the end of the fermentation (250 h). Yeast
extract and
peptonized milk were the main substrates required for
biomass
formation. In shake flask experiments, biomass could be formed
without addition of glucose or lactose to the complex medium (results
not shown).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Fermentation of A. terreus in complex medium
with lactose (53 g liter 1), peptonized milk (24 g
liter 1), and yeast extract (2.5 g liter 1)
at an aeration rate of 1 vvm and agitation speed of 400 rpm. ,
lactose; , biomass; , lovastatin.
|
|
Influence of nitrogen source in chemically defined medium.
To
investigate the effect of the substrates on lovastatin production, a
defined medium with a sole carbon source and a sole nitrogen source was
developed. Several inorganic and organic nitrogen sources were tested
in shake flask cultures using a defined medium with 45 g of
glucose liter
1 as the carbon source (Table
1). Ammonia, which plays a central role
in nitrogen metabolism in filamentous fungi (2), was
tested beside urea and nitrate, which can be consumed by some fungi
(11). A. terreus grew on all nitrogen sources
listed in Table 1, indicating their consumption. Glucose was exhausted
after 140 h in all experiments except for that with ammonium
acetate (Table 1). Although inorganic nitrogen sources like ammonium
tartrate, ammonium nitrate, ammonium acetate, sodium nitrate, or urea
were consumed for biomass formation, lovastatin production was very
poor after 140 h of cultivation (Table 1 [first five rows of
data]).
Amino acids can act both as a nitrogen source and a carbon source in
filamentous fungi. Since no free ammonium could be detected
in the
supernatants (data not shown) during growth on amino acids,
we assume
that they were primarily used as a nitrogen source.
Best lovastatin
production was obtained with cultures grown on
sodium glutamate (12.5 g
liter
1) or histidine (12.5 g liter
1) (Table
1). A glutamate concentration of 12.5 g liter
1 was more
favorable than 7 or 18 g liter
1 (Table
1). Glycine,
arginine, and isoleucine (Table
1) were
assimilated but gave poor
lovastatin production. Because glutamate
was consumed twice as fast as
histidine during batch experiments
(data not shown), glutamate was
chosen as the nitrogen source
for the chemically defined medium in
order to allow rapid biomass
formation.
Influence of carbon source in chemically defined medium.
In
defined medium, the carbon and nitrogen sources play a critical role as
a source of precursors and cofactors for synthesis of biomass building
blocks and lovastatin production. In addition, the carbon source may
exert complex regulation on gene expression and enzyme activities for
polyketide synthesis. Lactose, glycerol, and ethanol as the sole C
source or combined with glucose were tested in shake flasks cultures
with sodium glutamate (12.5 g liter
1) as the
nitrogen source. Lovastatin concentration, residual carbon source, and
residual glutamate concentrations were measured 160 h after inoculation.
All single and combinations of carbon sources could be assimilated by
A. terreus (Table
2). However,
when used as the unique
carbon source, lactose and ethanol were not
completely exhausted
after 140 h of cultivation in shake flasks
(Table
2). The highest
lovastatin production was obtained in the
experiment with 20 or
45 g of glucose liter
1 and for
growth on 45 g of lactose liter
1 (Table
2). Varying
the initial glucose concentration from 20
to 45 g
liter
1 had little effect on lovastatin concentration. By
contrast, increasing
the initial glucose concentration to 70 g
liter
1 led to a significant decrease in lovastatin
production (Table
2). After 160 h of culture, only traces of
lovastatin were detected
and 31 mg liter
1 were produced
after 340 h. As observed during a batch experiment
on complex
medium with lactose (Fig.
2), lovastatin production
was detected on
defined medium at high residual lactose concentrations
(Table
2).
Ethanol and glycerol are reduced substrates that generate NADH, which
is required for the biosynthesis of polyketides (
27,
37).
However, these two substrates proved to be very poor substrates
for
lovastatin production (Table
2). Furthermore, consumption
of ethanol
was very slow. Also a combination of glucose with ethanol
resulted in
poor lovastatin production (Table
2). Combination
of glycerol with
glucose (20 g liter
1 each) gave results similar to those
of glucose alone (37 and
33 mg liter
1, respectively)
(Table
2). By contrast, a combination of lactose
with glucose (20 g
liter
1 each) (Table
2) gave almost as much as the sum of
glucose and
lactose alone (54 compared to 37 and 25 mg
liter
1, respectively). This indicates that a combination
of both a rapidly
and a slowly metabolized sugar may be beneficial to
lovastatin
production.
Batch cultures of A. terreus in chemically defined
medium.
A batch cultivation experiment was performed on synthetic
medium containing 45 g of glucose liter
1 and
12.5 g of sodium glutamate liter
1 as unique carbon
and nitrogen sources, respectively. Fig.
3A shows that glutamate was exhausted
after about 60 h of cultivation, while glucose was exhausted after
about 130 h. No ammonium was detected in the culture supernatant
throughout the experiment. The biomass concentration reached 9.5 g
liter
1 at the time of glutamate exhaustion. On synthetic
medium the specific growth rate was lower than on complex medium (0.052 and 0.07 h
1, respectively), and biomass yield on glucose
was lower (0.25 and 0.55 g g
1, respectively),
resulting in a period of glucose consumption three times longer than
that on complex medium. The glucose specific consumption rate,
qglucose, was 0.196 g g
1
h
1, and the glutamate specific consumption rate,
qglutamate, was 0.045 g g
1
h
1. Metabolism remained purely oxidative. Both the oxygen
uptake rate and the carbon dioxide production rate increased during the fermentation (Fig. 3C). Maximal values were observed after 61 h of
cultivation when glutamate became limiting; the oxygen uptake rate
reached 18 mmol h
1, and the carbon dioxide production
rate reached 24 mmol h
1. Gas exchange rates were lower
than those during growth on complex medium because glucose was
metabolized significantly slower.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Fermentation of A. terreus in chemically
defined medium with glucose (40 g liter 1) and glutamic
acid (9.8 g liter 1) at an aeration rate of 1 vvm and
agitation speed of 400 rpm. (A) Symbols: , glucose; , biomass;
, glutamic acid; , lovastatin. (B) Symbols: , oxygen
consumption rate rO2; , carbon dioxide
production rate rCO2.
|
|
Production of lovastatin in synthetic medium initiated when glucose
concentration dropped below 10 g liter
1 (Fig.
3A).
The specific production rate of lovastatin reached
0.093 mg
g
1 h
1 after glucose exhaustion, i.e., about
three times higher than
that on complex medium. A concentration of 220 mg liter
1 was measured after 13 days of cultivation. No
monacolin J, monacolin
L, or mevastatin was detected by mass
spectroscopy (results not
shown).
In order to determine whether lovastatin could be produced in the
presence of residual glutamate, the initial glucose concentration
was
set to 20 g liter
1, while the initial glutamate
concentration was kept to 12.5 g
liter
1. Lovastatin
started to accumulate slowly when the residual glucose
concentration
was about 10 g liter
1. More than 5 g of
glutamate liter
1 remained in the culture supernatant when
glucose exhaustion occurred.
At that time point the rate of lovastatin
biosynthesis increased
while glutamate was still present in culture
supernatant (data
not
shown).
 |
DISCUSSION |
In filamentous fungi, biosynthesis of secondary metabolites is
subject to complex regulations. This study focused on the influence of
N and C sources on the regulation of lovastatin biosynthesis in
A. terreus. Under all cultivation conditions, in complex and defined media, A. terreus produced neither monacolin J nor
monacolin L nor mevastatin.
Since growth requirements of A. terreus are limited, a
chemically defined medium could be developed. The buffer capacity of this medium allowed us to keep the pH between 6.2 and 7.0. In the
defined medium, all nitrogen sources tested (Table 2) were consumed,
which was confirmed by biomass formation. However, lovastatin biosynthesis proved dependent on the nitrogen source, as no lovastatin was detected during cultivation in presence of ammonium, nitrate, or
urea (Table 1). Only glutamate and histidine, and to a lesser extent
glycine, supported lovastatin biosynthesis. Study of NAD- and
NADP-glutamate dehydrogenase showed that glutamate and histidine play a
key role in generation of idiophase conditions by the formation of
-ketoglutarate, which stimulates aflatoxin formation by inhibition of the tricarboxylic acid cycle (3). The influence of
nitrogen sources on secondary metabolism has been illustrated for
fumonisin B1 biosynthesis in Gibberella fujikuroi
(32), for sterigmatocystin (10) and aflatoxin
(6, 20) biosynthesis in Aspergillus nidulans
and Aspergillus parasiticus, and for penicillin synthesis in
Penicillium chrysogenum (9).
During growth on complex medium (glucose, peptonized milk, and yeast
extract), glucose was rapidly metabolized under high oxygen consumption
and biomass was formed (Fig. 1). Ethanol was also formed, probably as
result of a glycolytic overflow. Lactose and ethanol were consumed only
after glucose exhaustion. The onset of lovastatin biosynthesis after
glucose consumption can be attributed either to relief from carbon
catabolite repression or to carbon source limitation. Carbon catabolite
repression in Aspergillus is mediated by the negative-acting
creA gene product (30, 35). The binding of
protein CreAp to specific promoter sites of structural or regulatory
genes involved in the utilization of alternative carbon sources,
prevents their expression in the presence of glucose or another
repressing carbon source (e.g., for alc genes see reference 29 and for endoglucanase encoded by egl1 see
reference 12). The utilization of ethanol in A. nidulans is repressed by double lock control by CreAp of activator
alcR and structural gene alcA, encoding alcohol
dehydrogenase I (19). The lovastatin biosynthetic gene
cluster consists of 18 putative open reading frames (ORFs) (18), among which 2 were annotated to encode regulatory
proteins, lovE and ORF 13. Analysis of the lovastatin
biosynthetic gene cluster revealed that closely spaced SYGGRG consensus
sequences, the motif of functional CreAp binding sites in vivo
(25), are present in the 5'-proximal region of ORF 13 [SYGGRG(N)15SYGGRG] and in the putative
promoter of the divergently transcribed ORF 8 and lovE
[SYGGRG(N)7CYCCRW]. The presence of
putative functional CreAp binding sites in two putative regulatory
genes suggests that repression of lovastatin biosynthesis by glucose
could be mediated by CreAp. Other carbon catabolite repression
mechanisms might also be involved. Glucose represses penicillin
synthesis in P. chrysogenum (9) by repressing
pcbAB, pcbC, and penD, whereas in A. nidulans only pcbC is strongly repressed by glucose. In
both species glucose repression of penicillin biosynthesis is not
exclusively mediated by creA (8) but is
mediated by another putative DNA-binding protein (24).
Batch experiments on lactose as the unique carbon source showed that
lactose was consumed by A. terreus (Fig. 2) but consumption stopped when the residual concentration was 25 g
liter
1. Lovastatin biosynthesis was low during ethanol
and glycerol consumption in shake flasks (Table 2). As nonrepressing
carbon sources, lactose, ethanol, and glycerol cannot activate CreAp. Interestingly, lovastatin biosynthesis started only when lactose consumption had stopped. This suggests that lovastatin synthesis was
elicited at the cessation of substrate consumption or growth limitation, i.e., under starvation conditions. The role of starvation in secondary metabolism was illustrated in Trichoderma
atroviride, in which chitinase gene ech42 is only
expressed after glucose or glycerol starvation (21). An
implication of starvation as an eliciting factor has been demonstrated
for the induction of sterigmatocystin in A. nidulans
(17, 34). The transcriptional regulator aflR is
regulated by flbA, fluG, and aflR, showing that both asexual sporulation and sterigmatocystin require inactivation of
proliferative growth through inhibition of fadA-dependent
signaling (17). In A. nidulans, brlA plays a
central role in the switch from vegetative growth to sporulation, and
glucose starvation induces high expression levels of brlA
(34).
A connection between secondary metabolism and sporulation was
demonstrated in Streptomyces griseus, where a
-butyrolactone-containing compound called A factor binds the ArpA
DNA-binding protein, which in turn is no longer able to function as the
negative regulator of genes required for sporulation and antibiotic
production (31). These authors showed that addition of
butyrolactone I (a
-butyrolactone-containing compound inhibiting
cyclin-dependent kinases which control cell cycle progression) to
cultures of A. terreus resulted in submerged sporulation and
increased production of lovastatin.
A threefold-higher specific productivity was found with the defined
medium on glucose and glutamate as compared to complex medium with
glucose, yeast extract, and peptonized milk. An explanation might be
that stringent starvation conditions are required: in defined medium
the only organic substrates are glucose and glutamate or histidine.
Once they have been exhausted no alternative organic compound is
available to the cells. By comparison, in a complex medium strict
starvation conditions may not apply after glucose exhaustion.
 |
ACKNOWLEDGMENTS |
We thank M. Richard and P. A. Richon for technical
assistance and P. van den Broek for stimulating discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Nestlé
Research Center, Nestec Ltd., Vers-chez-les-Blanc, P.O. Box 44, CH-1000
Lausanne 26, Switzerland. Phone: 41 21 785 8361. Fax: 41 21 785 8549. E-mail: philippe.duboc{at}rdls.nestle.com.
 |
REFERENCES |
| 1.
|
Alberts, A. W.,
J. Chen,
G. Kuron,
V. Hunt,
J. Huff,
C. Hoffman,
J. Rothrock,
M. Lopez,
H. Joshua,
E. Harris,
A. Patchett,
R. Monaghan,
S. Currie,
E. Stapley,
G. Albers-Schonberg,
O. Hensens,
J. Hirshfield,
K. Hoogsteen,
J. Liesch, and J. Springer.
1980.
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
Proc. Natl. Acad. Sci. USA
77:3957-3961[Abstract/Free Full Text].
|
| 2.
|
Andrianopoulos, A.,
S. Kourambas,
J. A. Sharp,
M. A. Davis, and M. J. Hynes.
1998.
Characterization of the Aspergillus nidulans nmrA gene involved in nitrogen metabolite repression.
J. Bacteriol.
180:1973-1977[Abstract/Free Full Text].
|
| 3.
|
Bhatnagar, R. K.,
S. Ahmad,
K. G. Mukerji, and T. A. Venkitasubramanian.
1986.
Nitrogen metabolism in Aspergillus parasiticus NRRL 3240 and A. flavus NRRL 3537 in relation to aflatoxin production.
J. Appl. Bacteriol.
60:203-211[Medline].
|
| 4.
|
Buckland, B.,
K. Gbewonyo,
T. Hallada,
L. Kaplan, and P. Masurekar.
1989.
Production of lovastatin, an inhibitor of cholesterol accumulation in humans, p. 161-169.
In
A. L. Demain, G. A. Somkuti, J. C. Hunter-Cevera, and H. W. Rossmoore (ed.), Novel microbial products for medicine and agriculture. Society for Industrial Microbiology. Elsevier Science Ltd., Amsterdam, The Netherlands.
|
| 5.
|
Chan, J. K.,
R. N. Moore,
T. T. Nakashima, and J. C. Vederas.
1983.
Biosynthesis of mevinolin. Spectral assignment by double-quantum coherence NMR after high carbon-13 incorporation.
J. Am. Chem. Soc.
105:3334-3336[CrossRef].
|
| 6.
|
Chang, P. K.,
K. C. Ehrlich,
J. Yu,
D. Bhatnagar, and T. E. Cleveland.
1995.
Increased expression of Aspergillus parasiticus aflR, encoding a sequence-specific DNA-binding protein, relieves nitrate inhibition of aflatoxin biosynthesis.
Appl. Environ. Microbiol.
61:2372-2377[Abstract].
|
| 7.
|
Endo, A.
1979.
Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.
J. Antibiot.
32:852-854[Medline].
|
| 8.
|
Espeso, E. A.,
J. Tilburn,
H. N. Arst, Jr., and M. A. Penalva.
1993.
pH regulation is a major determinant in expression of a fungal penicillin biosynthetic gene.
EMBO J.
12:3947-3956[Medline].
|
| 9.
|
Feng, B.,
E. Friedlin, and G. A. Marzluf.
1994.
A reporter gene analysis of penicillin biosynthesis gene expression in Penicillium chrysogenum and its regulation by nitrogen and glucose catabolite repression.
Appl. Environ. Microbiol.
60:4432-4439[Abstract/Free Full Text].
|
| 10.
|
Feng, G. H., and T. J. Leonard.
1998.
Culture conditions control expression of the genes for aflatoxin and sterigmatocystin biosynthesis in Aspergillus parasiticus and A. nidulans.
Appl. Environ. Microbiol.
64:2275-2277[Abstract/Free Full Text].
|
| 11.
|
Garrett, R. H., and N. K. Amy.
1978.
Nitrate assimilation in fungi.
Adv. Microb. Physiol.
18:1-65[Medline].
|
| 12.
|
Gonzalez, R.,
J. A. Perez-Gonzalez,
L. Gonzalez-Candelas, and D. Ramon.
1994.
Transcriptional regulation of the Trichoderma longibrachiatum egl1 gene.
FEMS Microbiol. Lett.
122:303-307[CrossRef][Medline].
|
| 13.
|
Greenspan, M. D., and J. B. Yudkovitz.
1985.
Mevinolinic acid biosynthesis by Aspergillus terreus and its relationship to fatty acid biosynthesis.
J. Bacteriol.
162:704-707[Abstract/Free Full Text].
|
| 14.
|
Gunde-Cimerman, N.,
A. Plemenitas, and A. Cimerman.
1993.
Pleurotus fungi produce mevinolin, an inhibitor of HGM CoA reductase.
FEMS Microbiol. Lett.
133:333-338.
|
| 15.
|
Hajjaj, H.,
A. Klaebe,
M. O. Loret,
T. Tzedakis,
G. Goma, and P. J. Blanc.
1997.
Production and identification of N-glucosylrubropunctamine and N-glucosylmonascorubramine from Monascus ruber and the occurrence of electron donor-acceptor complexes in these red pigments.
Appl. Environ. Microbiol.
63:2671-2678[Abstract].
|
| 16.
|
Hendrickson, L.,
C. R. Davis,
C. Roach,
D. K. Nguyen,
T. Aldrich,
P. C. McAda, and C. D. Reeves.
1999.
Lovastatin biosynthesis in Aspergillus terreus: characterization of blocked mutants, enzyme activities and a multifunctional polyketide synthase gene.
Chem. Biol.
6:429-439[CrossRef][Medline].
|
| 17.
|
Hicks, J. K.,
J. Yu,
N. P. Keller, and T. Adams.
1997.
Aspergillus sporulation and mycotoxin production both require inactivation of the FadA G protein-dependent signaling pathway.
EMBO J.
16:4916-4923[CrossRef][Medline].
|
| 18.
|
Kennedy, J.,
K. Auclair,
S. G. Kendrew,
C. Park,
J. C. Vederas, and C. R. Hutchinson.
1999.
Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis.
Science
284:1368-1372[Abstract/Free Full Text].
|
| 19.
|
Kulmburg, P.,
M. Mathieu,
C. Dowzer,
J. Kelly, and B. Felenbok.
1993.
Specific binding sites in the alcR and alcA promoters of the ethanol regulon for the CREA repressor mediating carbon catabolite repression in Aspergillus nidulans.
Mol. Microbiol.
7:847-857[CrossRef][Medline].
|
| 20.
|
Luchese, R. H., and W. F. Harrigan.
1993.
Biosynthesis of aflatoxin the role of nutritional factors.
J. Appl. Bacteriol.
74:5-14[Medline].
|
| 21.
|
Mach, R. L.,
C. K. Peterbauer,
K. Payer,
S. Jaksits,
S. L. Woo,
S. Zeilinger,
C. M. Kullnig,
M. Lorito, and C. P. Kubicek.
1999.
Expression of two major chitinase genes of Trichoderma atroviride (T. harzianum P1) is triggered by different regulatory signals Appl.
Environ. Microbiol.
65:1858-1863.
|
| 22.
|
Manzoni, M.,
M. Rollini,
S. Bergomi, and V. Cavazzoni.
1998.
Production and purification of statins from Aspergillus terreus strains.
Biotechnol. Techniques
12:529-532[CrossRef].
|
| 23.
|
Manzoni, M.,
S. Bergomi,
M. Rollini, and V. Cavazzoni.
1999.
Production of statins by filamentous fungi.
Biotechnol. Lett.
21:253-257.
|
| 24.
|
Martin, J. F.,
J. Casqueiro,
K. Kosalkova,
A. T. Marcos, and S. Gutierrez.
1999.
Penicillin and cephalosporin biosynthesis: mechanism of carbon catabolite regulation of penicillin production.
Antonie Leeuwenhoek
75:21-31.
|
| 25.
|
Mathieu, M.,
S. Fillinger, and B. Felenbock.
2000.
In vivo studies of upstream regulatory cis-acting elements of the alcR gene encoding the transactivator of the ethanol regulon in Aspergillus nidulans.
Mol. Microbiol.
36:123-131[CrossRef][Medline].
|
| 26.
|
Moore, R. N.,
G. Bigam,
J. K. Chan,
A. M. Hogg,
T. T. Nakashima, and J. C. Vederas.
1985.
Biosynthesis of the hypocholesterolemic agent mevinolin by Aspergillus terreus. Determination of the origin of carbon, hydrogen, and oxygen by 13C NMR and mass spectroscopy.
J. Am. Chem. Soc.
107:3694-3701[CrossRef].
|
| 27.
|
Niehaus, W. G., and R. P. Dilts.
1982.
Purification and characterization of mannitol dehydrogenase from Aspergillus parasiticus.
J. Bacteriol.
151:243-250[Abstract/Free Full Text].
|
| 28.
|
Novak, N.,
S. Gerdin, and M. Berovic.
1997.
Increased lovastatin formation by Aspergillus terreus using repeated fed-batch process.
Biotechnol. Lett.
19:947-948[CrossRef].
|
| 29.
|
Panozzo, C.,
E. Cornillot, and B. Felenbok.
1998.
The CreA repressor is the sole DNA-binding protein responsible for carbon catabolite repression of the alcA gene in Aspergillus nidulans via its binding to a couple of specific sites.
J. Biol. Chem.
273:6367-6372[Abstract/Free Full Text].
|
| 30.
|
Ruijter, G. J., and J. Visser.
1997.
Carbon repression in Aspergilli.
FEMS Microbiol. Lett.
151:103-114[CrossRef][Medline].
|
| 31.
|
Schimmel, T. G.,
A. D. Coffman, and S. J. Parsons.
1998.
Effect of butyrolactone I on the producing fungus, Aspergillus terreus.
Appl. Environ. Microbiol.
64:3707-3712[Abstract/Free Full Text].
|
| 32.
|
Shim, W. B., and C. P. Woloshuk.
1999.
Nitrogen repression of fumonisin B1 biosynthesis in Gibberella fujikuroi.
FEMS Microbiol. Lett.
177:109-116[CrossRef][Medline].
|
| 33.
|
Simpson, T. J.
1986.
Studies of polyketide chain-assembly processes, p. 85-96.
Elsevier, Amsterdam, The Netherlands.
|
| 34.
|
Skromne, L.,
O. Sanchez, and J. Aguirre.
1995.
Starvation stress modulates the expression of the Aspergillus nidulans brlA regulatory gene.
Microbiology
141:21-28[Abstract/Free Full Text].
|
| 35.
|
Strauss, J.,
H. K. Horvath,
B. M. Abdallah,
J. Kindermann,
R. L. Mach, and C. P. Kubicek.
1999.
The function of CreA, the carbon catabolite repressor of Aspergillus nidulans, is regulated at the transcriptional and post-transcriptional level.
Mol. Microbiol.
32:169-178[CrossRef][Medline].
|
| 36.
|
Treiber, L. R., and R. A. Reamer.
1989.
Origin of monacolin L from Aspergillus terreus cultures.
J. Antibiot.
XLII:30-36.
|
| 37.
|
Turner, W. B.
1971.
Fungal metabolites: polyketides, p. 445-476.
Academic Press, London, United Kingdom.
|
| 38.
|
Yoshizawa, Y.,
D. J. Witter,
Y. Liu, and J. C. Vederas.
1994.
Revision of the biosynthetic origin of oxygens in mevinolin (lovastatin), a hypocholesterolemic drug from Aspergillus terreus MF 4845.
J. Am. Chem. Soc.
116:2693-2694[CrossRef].
|
Applied and Environmental Microbiology, June 2001, p. 2596-2602, Vol. 67, No. 6
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.6.2596-2602.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.